Randomized Phase II Trial Of Hypofractionated Dose-Escalated Photon Imrt Or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant And Adjuvant Temozolomide In Patients With Newly Diagnosed Glioblastoma
Posted Date: Jan 18, 2018
- Investigator: Kevin Redmond
- Specialties: Hematology/Oncology, Oncology, Cancer
- Type of Study: Drug
The purpose of this study is to compare a different radiation therapy schedule and higher radiation dose to the standard dose of radiation therapy. All patients will receive usual chemotherapy, temozolomide. This study will allow researchers to know whether this higher dose is better, the same, or worse than the usual approach. To be better, the study should increase life by six months or more compared to the usual approach. Two methods of giving radiation therapy will also be compared. They are proton beam radiation and intensity-modulated radiation.
To Be Eligible For This Study, Patients Must Have A Brain Tumor Called Glioblastoma.
Tumor, Brain , Cancer, Glioblastoma, Nrg-Bn001
For More Information:
Uc Cancer Institute